NCPA Blasts FTC for Failing to Investigate PBMs

Hoey: “You let the worst actors in the market off the hook”

NCPA February 17, 2022

Alexandria, VA (February 17, 2022) – The National Community Pharmacists Association (NCPA) issued the following statement on behalf of NCPA CEO B. Douglas Hoey in reaction to a deadlock vote by the FTC on whether to investigate PBMs, effectively killing the proposal at least for now:

“Two members of the FTC just let the worst actors in the market off the hook. After hearing hours of testimony by community pharmacists and patients, all of whom painted the same shocking picture about PBM abuse, and not a single witness there to defend the PBM industry, it is inexplicable that two members of the commission could vote against the study. Their decisions could not possibly have been based on what was heard today.

“We’re grateful to Chairwoman Khan for bringing this issue to a vote. We will demand she do so again at the soonest possible opportunity. However, this is extremely disappointing.”

For more information about NCPA, please visit


Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing nearly 19,400 pharmacies that employ approximately 215,000 individuals nationwide. Community pharmacies are rooted in the communities where they are located and are among America’s most accessible health care providers. To learn more, visit